Literature DB >> 19008740

Ischemic optic neuropathies.

Katie Luneau1, Nancy J Newman, Valérie Biousse.   

Abstract

Anterior ischemic optic neuropathy (AION) is the most common cause of acute optic neuropathy after age 50, but may also occur in younger patients. The diagnosis is clinical and includes painless visual loss associated with a relative afferent pupillary defect and disc edema. In almost all cases, there is an underlying crowded optic nerve with a small cup-to-disc ratio. The visual prognosis is usually poor, although up to 43% of patients may improve over time. The fellow eye is involved in up to 15% of patients within 5 years, but the risk of recurrence in the same eye is less than 5%. There is no treatment for acute nonarteritic AION but it is essential to evaluate these patients for underlying treatable atheromatous vascular risk factors. A coagulation workup should also be considered in younger patients. It is essential to rule out giant cell arteritis in all patients over the age of 50 with ischemic optic neuropathies. Posterior ischemic neuropathy (in which the optic nerve is normal acutely) is rare and should be considered a diagnosis of exclusion.

Entities:  

Mesh:

Year:  2008        PMID: 19008740     DOI: 10.1097/NRL.0b013e318177394b

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  19 in total

1.  Eye syndromes and the neuro-ophthalmology of stroke.

Authors:  Valérie Biousse; Nancy J Newman
Journal:  Handb Clin Neurol       Date:  2009

Review 2.  Amiodarone-Associated Optic Neuropathy: Clinical Review.

Authors:  An-Guor Wang; Hui-Chen Cheng
Journal:  Neuroophthalmology       Date:  2016-11-18

3.  Risk Factors for Non-arteritic Anterior Ischaemic Optic Neuropathy in a Korean Population.

Authors:  Dae Hyun Kim; Gwang Rae Shin; Young Je Choi
Journal:  Neuroophthalmology       Date:  2017-01-11

4.  Imageology of internal carotid artery siphon in non-arteritic anterior ischaemic optic neuropathy.

Authors:  Zhi-Yong Fu; Hong-Yang Li; Yan-Ling Wang
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

Review 5.  Amaurosis after spine surgery: survey of the literature and discussion of one case.

Authors:  Stephan Zimmerer; Markus Koehler; Stephanie Turtschi; Anja Palmowski-Wolfe; Thierry Girard
Journal:  Eur Spine J       Date:  2010-09-01       Impact factor: 3.134

6.  Vascular neuro-ophthalmology.

Authors:  Cédric Lamirel; Nancy J Newman; Valérie Biousse
Journal:  Neurol Clin       Date:  2010-08       Impact factor: 3.806

Review 7.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

8.  Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy.

Authors:  Valerie Touitou; Mary A Johnson; Yan Guo; Neil R Miller; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-11       Impact factor: 4.799

9.  The effect of high-dose steroids, and normobaric oxygen therapy, on recent onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial.

Authors:  Mohammad Pakravan; Nasrin Sanjari; Hamed Esfandiari; Parastou Pakravan; Mehdi Yaseri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-10       Impact factor: 3.117

10.  Optic neuritis, its differential diagnosis and management.

Authors:  Hedieh Hoorbakht; Farid Bagherkashi
Journal:  Open Ophthalmol J       Date:  2012-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.